Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF CASH FLOWS

v2.4.0.8
CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)
9 Months Ended
Jul. 31, 2014
Jul. 31, 2013
Cash flows used in operating activities    
Net (loss) for the period $ (1,171,591) $ (217,283)
Adjustments to reconcile net loss to net cash used in operating activities:    
Consulting - Stock based compensation 636,914 21,279
Depletion 161,112 282,533
Foreign exchange (gain) loss 0 (6,799)
Joint venture - equity loss pick-up 8,413 0
Change in operating assets and liabilities:    
(Increase)/Decrease in accounts receivable (19,466) 139,117
(Increase)/ Decrease in prepaid expenses and deposit (40,668) (1,506)
Increase in accounts payable and accrued liabilities 13,607 29,385
Net cash used in operating activities (411,679) 246,726
Cash flows used in investing activities    
Oil and gas property acquisition and exploration costs (56,422) (64,381)
Medical Marijuana Investments (51,562) 0
Net cash used in investing activities (107,984) (64,381)
Cash flows from financing activities    
Payments of loan payable (278,059) (335,330)
Proceeds from private placement, convertible debt, and option exercise 1,310,655 0
Net cash from financing Activities 1,032,596 (335,330)
Increase (Decrease) in cash and cash equivalents 512,933 (152,985)
Cash and cash equivalents, beginning of period 65,542 180,514
Cash and cash equivalents, end of period 578,475 27,529
Supplemental information of cash flows:    
Interest paid in cash 147,166 166,632
Income taxes paid in cash $ 0 $ 0